Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Philip H Gutin
Antiangiogenic Agents in the Treatment of Recurrent or Newly Diagnosed Glioblastoma: Analysis of Single-Agent and Combined Modality Approaches
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
Controversies in the Treatment of Elderly Patients With Newly Diagnosed Glioblastoma
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Erratum To: Single-Agent Bevacizumab Is an Effective Treatment in Recurrent Glioblastoma
Medical Oncology
Medicine
Cancer Research
Oncology
Hematology
Using Temozolomide in Newly Diagnosed Glioblastoma Multiforme – A Single-Centre Experience
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
Cytotoxic Chemotherapeutic Management of Newly Diagnosed Glioblastoma Multiforme
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Prognostic Value of the S100B Protein in Newly Diagnosed and Recurrent Glioma Patients: A Serial Analysis
Journal of Neuro-Oncology
Cancer Research
Oncology
Neurology
Conservative Treatment of Newly Diagnosed Keratoconus
Acta Ophthalmologica
Medicine
Ophthalmology
Boron Neutron Capture Therapy for Newly Diagnosed Glioblastoma
Radiotherapy and Oncology
Nuclear Medicine
Oncology
Radiology
Hematology
Imaging
A Budget Impact Model for the Introduction of Bevacizumab for the Treatment of Newly Diagnosed Glioblastoma Multiforme in the UK
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Combined Modality Treatment of Anal Carcinoma
Oncologist
Cancer Research
Medicine
Oncology